A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease
- 29 March 2006
- journal article
- clinical trial
- Published by Elsevier BV in Vascular Pharmacology
- Vol. 44 (5), 372-376
- https://doi.org/10.1016/j.vph.2006.01.013
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pulmonary Hypertension and Right Heart Failure in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005
- Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunctionVascular Pharmacology, 2005
- Management of pulmonary hypertension resulting from interstitial lung diseaseCurrent Opinion in Pulmonary Medicine, 2003
- Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trialThe Lancet, 2002
- ATS StatementAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary HypertensionAnnals of Internal Medicine, 2002
- Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2001
- Intermediate-term results of heart-lung transplantation for cystic fibrosisThe Lancet, 1992